Robert P Lenk - Net Worth and Insider Trading

Robert P Lenk Net Worth

The estimated net worth of Robert P Lenk is at least $71,265 dollars as of 2024-06-06. Robert P Lenk is the Director of Plus Therapeutics Inc and owns about 29,327 shares of Plus Therapeutics Inc (PSTV) stock worth over $71,265. Details can be seen in Robert P Lenk's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert P Lenk has not made any transactions after 2024-05-08 and currently still holds the listed stock(s).

Transaction Summary of Robert P Lenk

To

Robert P Lenk Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert P Lenk owns 2 companies in total, including Plus Therapeutics Inc (PSTV) , and Luna Innovations Inc (LUNA) .

Click here to see the complete history of Robert P Lenk’s form 4 insider trades.

Insider Ownership Summary of Robert P Lenk

Ticker Comapny Transaction Date Type of Owner
PSTV Plus Therapeutics Inc 2024-05-08 director
LUNA Luna Innovations Inc 2006-06-02 President & Luna nanoWorks Div

Robert P Lenk Latest Holdings Summary

Robert P Lenk currently owns a total of 1 stock. Robert P Lenk owns 29,327 shares of Plus Therapeutics Inc (PSTV) as of May 8, 2024, with a value of $71,265.

Latest Holdings of Robert P Lenk

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PSTV Plus Therapeutics Inc 2024-05-08 29,327 2.43 71,265

Holding Weightings of Robert P Lenk


Robert P Lenk Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert P Lenk has made a total of 8 transactions in Plus Therapeutics Inc (PSTV) over the past 5 years, including 7 buys and 1 sells. The most-recent trade in Plus Therapeutics Inc is the acquisition of 4,167 shares on May 8, 2024, which cost Robert P Lenk around $8,501.

Insider Trading History of Robert P Lenk

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert P Lenk Trading Performance

GuruFocus tracks the stock performance after each of Robert P Lenk's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert P Lenk is 2.99%. GuruFocus also compares Robert P Lenk's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert P Lenk within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert P Lenk's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert P Lenk

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 16.33 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 13.66 LIMIT LIMIT LIMIT LIMIT LIMIT

Robert P Lenk Ownership Network

Ownership Network List of Robert P Lenk

No Data

Ownership Network Relation of Robert P Lenk

Insider Network Chart

Robert P Lenk Owned Company Details

What does Plus Therapeutics Inc do?

Who are the key executives at Plus Therapeutics Inc?

Robert P Lenk is the director of Plus Therapeutics Inc. Other key executives at Plus Therapeutics Inc include President Marc H Hedrick , Chief Financial Officer Sims Andrew John Hugh Macintyre , and CHIEF MEDICAL OFFICER Norman D. Lafrance .

Plus Therapeutics Inc (PSTV) Insider Trades Summary

Over the past 18 months, Robert P Lenk made 6 insider transaction in Plus Therapeutics Inc (PSTV) with a net purchase of 27,261. Other recent insider transactions involving Plus Therapeutics Inc (PSTV) include a net purchase of 20,297 shares made by Howard Clowes , a net purchase of 32,255 shares made by Greg Petersen , and a net purchase of 10,187 shares made by Marc H Hedrick .

In summary, during the past 3 months, insiders sold 0 shares of Plus Therapeutics Inc (PSTV) in total and bought 48,285 shares, with a net purchase of 48,285 shares. During the past 18 months, 3,568 shares of Plus Therapeutics Inc (PSTV) were sold and 103,372 shares were bought by its insiders, resulting in a net purchase of 99,804 shares.

Plus Therapeutics Inc (PSTV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Plus Therapeutics Inc Insider Transactions

No Available Data

Robert P Lenk Mailing Address

Above is the net worth, insider trading, and ownership report for Robert P Lenk. You might contact Robert P Lenk via mailing address: Luna Innovations Incorporated, 2851 Commerce Street, Blacksburg Va 24060.

Discussions on Robert P Lenk

No discussions yet.